相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存:
500-P17BT
- 靶点:
生物素标记FGF-acidic
- 级别:
科研
- 目录编号:
500-P17BT
- 克隆性:
多克隆
- 抗原来源:
Recombinant Human FGF-acidic (PeproTech catalog# 100-17A)
- 保质期:
Recombinant Human FGF-acidic (PeproTech catalog# 100-17A)
- 抗体英文名:
Biotinylated Anti-Human FGF-acidic
- 抗体名:
生物素标记FGF-acidic
- 标记物:
生物素标记FGF-acidic
- 宿主:
兔
- 适应物种:
人
- 应用范围:
WB ELISA
- 浓度:
Biotinylated Anti-Human FGF-acidic
- 规格:
25ug
产品详情
产品编号: 500-P17BT
资料来源:多克隆兔
制备:由高纯度(>98%)重组hFGF酸性预免疫兔血清制备。通过亲和层析纯化抗人FGF酸性特异性抗体,然后进行生物素化。
免疫原:大肠杆菌衍生的重组人酸性FGF(PeproTech目录#100-17A)
夹心ELISA:要通过夹心ELISA(使用100μl/孔抗体溶液)检测酸性hFGF,需要浓度为0.25–1.0μg/ml的这种抗体。这种生物素化的多克隆抗体,结合PeproTech的多克隆抗人FGF酸性(500-P17)作为捕获抗体,允许检测至少0.2–0.4 ng/孔的重组hFGF酸性。
生物素化抗人FGF酸性夹心ELISA
Western Blot:为了通过Western Blot分析检测酸性hFGF,该抗体可在0.1-0.2µg/ml的浓度下使用。与兼容的二级试剂结合使用,在还原或非还原条件下,重组酸性hFGF的检测限为1.5-3.0 ng/lane。
| 500-P17Bt-25 | Biotinylated Rabbit Anti-Human FGF-acidic | 25ug |
| 500-P17Bt-50 | Biotinylated Rabbit Anti-Human FGF-acidic | 50ug |
| 500-P17Bt-1000 | Biotinylated Rabbit Anti-Human FGF-acidic | 1000ug |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Biotinylated Primer for Detecting Telomerase Activity Without Amplification
to be an attractive new target for designing anti-cancer agents, as well as an important diagnostic marker of human cancer (5 -7 ). For these reasons, it is necessary to develop telomerase assay methods that can be used for the quantitative measurement of telomerase
and memory in aged mice via Fgf17. Nature (2022). 2. Castellano, J. M. et al. Human umbilical cord plasma proteins revitalize hippocampal function in aged mice. Nature 544, 488–492 (2017). 3. Fame, R. M. & Lehtinen, M. K. Emergence and developmental roles
-human immunoglobulin (Ig)A, anti-human IgM and anti-human IgE were developed for the simultaneous capture of total IgG, IgA, IgM and IgE (IgGAME) antibodies from human or non-human primate serum. The fraction of antigen-specific antibodies captured
技术资料暂无技术资料 索取技术资料









